Substance-Related and Addictive Disorders in Mental Health Quiz

The DSM-5, a key resource for mental health professionals, is published by the American Psychiatric Association (APA).

Stimulant drugs like cocaine and amphetamines primarily affect the neurotransmitter dopamine, contributing to their stimulating and euphoric effects.

Bupropion is commonly used for smoking cessation, reducing withdrawal symptoms and cravings for nicotine.

The term for the process by which the body adjusts to the presence of a substance, leading to reduced effects over time, is 'tolerance.'

The term for the experience of negative psychological and physical symptoms when a person stops using a substance is 'withdrawal,' reflecting the body's adjustment to the absence of the substance.

LSD is a hallucinogenic substance known for its profound effects on perception, mood, and consciousness.

Insomnia is a common withdrawal symptom in individuals experiencing alcohol dependence, disrupting sleep patterns.

Opioid agonists/antagonists are commonly used to treat opioid dependence by reducing withdrawal symptoms and cravings, helping individuals achieve recovery.

Tolerance in substance-related disorders refers to the need for increased amounts of the substance to achieve the desired effect, indicating reduced responsiveness over time.

Cirrhosis is a long-term consequence of heavy alcohol consumption, characterized by inflammation and scarring of the liver.

Cross-tolerance in substance-related disorders refers to tolerance to one substance leading to tolerance to another, often observed with substances sharing similar mechanisms of action.

Dopamine is often associated with the pleasure and reward system in the brain, playing a central role in the context of substance abuse.

Dopamine is the primary neurotransmitter associated with the rewarding effects of drugs, contributing to the pleasure and reinforcement of substance use.

Financial stability is not a criterion for diagnosing Substance Use Disorder according to the DSM-5; criteria focus on patterns of substance use and associated impairment.

Delta-9-tetrahydrocannabinol (THC) is the primary psychoactive compound in cannabis responsible for its euphoric effects.

Impaired control refers to the phenomenon where an individual continues substance use despite being aware of the associated harmful consequences, indicating a loss of control over use.

The primary purpose of methadone maintenance therapy in opioid use disorder treatment is to eliminate withdrawal symptoms, aiding in recovery.

The term for the repeated use of a substance that results in a higher dose needed to achieve the desired effect is 'tolerance,' indicating a diminishing response over time.

Cue-reactivity is the phenomenon where a person experiences intense cravings and physical reactions when exposed to cues associated with substance use, reflecting the conditioned nature of drug-seeking behavior.